High efficacy of disopyramide in the management of ventricular fibrillation storms in a patient with Brugada syndrome

PACE - Pacing and Clinical Electrophysiology

Volumn 33, Issue 6, 2010, Pages

  Sumi, Shunichiro ^a   Maruyama, Seiyo ^a   Shiga, Yuhei ^a   Kodama, Sunao ^a   Miyoshi, Kei ^a   Tojou, Hideaki ^a   Yamanouchi, Yoshio ^a   Urata, Hidenori ^a  

^a Fukuoka University Chikushi Hospital   (Japan)

Author keywords

Defibrillation ICD; Pharmacology

Indexed keywords

DISOPYRAMIDE; PILSICAINIDE; ANTIARRHYTHMIC AGENT; QUINIDINE;

ADULT; ARTICLE; BRUGADA SYNDROME; CASE REPORT; DEFIBRILLATOR; DRUG EFFICACY; ELECTROCARDIOGRAM; HEART VENTRICLE FIBRILLATION; HUMAN; MALE; ELECTROCARDIOGRAPHY; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; MIDDLE AGED; VENTRICULAR FIBRILLATION;

ANTI-ARRHYTHMIA AGENTS; BRUGADA SYNDROME; DEFIBRILLATORS, IMPLANTABLE; DISOPYRAMIDE; ELECTROCARDIOGRAPHY; HUMANS; MALE; MIDDLE AGED; QUINIDINE; VENTRICULAR FIBRILLATION;

EID: 77953198614     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2009.02665.x     Document Type: Article

References (12)

1. Watanabe A, Fukushima Kusano K, Morita H, Miura D, Sumida W, Hiramatus S, Banba K, et al. Low-dose isoproternol for repetitive ventricular arrhythmia in patients with Brugada syndrome. Eur Heart J 2006 27:1579-1583.
2. Ohgo T, Okamura H, Noda T, Satomi K, Suyama K, Kurita T, Aihara N, et al. Acute and chronic management in patients with Brugada syndrome associated with electrical storm of ventricular fibrillation. Heart Rhythm 2007 4:695-700.
3. Marquez MF, Rivera J, Hermosillo AG, Iturralde P, Colin L, Moragrega JL, Cardenas M. Arrhythmic storm responsive to quinidine in a patient with Brugada syndrome and vasovagal syncope. Pacing Clin Electrophysiol 2005 28:870-873.
4. Mok NS, Chan NY, Chiu ACS. Successful use of quinidine in treatment of electrical storm in Brugada syndrome. Pacing Clin Electrophysiol 2004 27:821-823.
5. Shimizu W, Antzelevitch C, Suyama K, Kurita T, Taguchi A, Aihara N, Takaki H, et al. Effect of sodium channel blockers on ST segment, QRS duration, and corrected QT interval in patients with Brugada syndrome. J Cardiovasc Electrophysiol 2000 11:1320-1329.
6. Antzelevitch C, Brugada P, Borggrefe M, Brugada J, Brugada R, Corrado D, Gussak I, et al. Brugada syndrome: Report of the second consensus conference. Heart Rhythm 2005 2:429-440. (Pubitemid 40439292)
7. Litovsky SH, Antzelevitch C. Differences in the electrophysiological response of canine ventricular subendocardium and subepicardium to acetylcholine and isoproterenol. A direct effect of acetylcholine in ventricular myocardium. Circ Res 1990 67:615-627.
8. Hermida HS, Denjoy I, Clerc J, Extramiana F, Jarry G, Milliez P, Guicheney P, et al. Hydroquinidine therapy in Brugada syndrome. J Am Coll Cardiol 2004 43:1853-1860.
9. Belhassen B, Glick A, Viskin S. Efficacy of quinidine in high-risk patients with Brugada syndrome. Circulation 2004 110:1731-1737.
10. Sugao M, Fujiki A, Nishida K, Sakabe M, Tsuneda T, Iwamoto J, Mizumaki K, et al. Repolarization dynamics in patients with idiopathic ventricular fibrillation: Pharmacological therapy with bepridil and disopyramide. J Cardiovasc Pharmacol 2005 45:545-549.
11. Chinushi M, Aizawa Y, Ogawa Y, Shiba M, Takahashi K. Discrepant drug action of disopyramide on ECG abnormalities and induction of ventricular arrythmias in a patient with Brugada syndrome. J Electrocardiol 1997 30:133-136.
12. Yatani A, Akaike N. Blockage of the sodium current in isolated single cells from rat ventricle with mexiletine and disopyramide. J Mol Cell Cardiol 1985 17:467-476.